Treatment of stage II malignant melanoma patients with a Newcastle disease virus oncolysate.
Cassel
W A
WA
Murray
D R
DR
D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D009522:Newcastle disease virus / Q000276:immunology*; D014765:Viral Vaccines / Q000627:therapeutic use*
D014765:Viral Vaccines